<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.eurjchem.com/lib/pkp/xml/oai2.xsl" ?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/
		http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
	<responseDate>2026-05-09T13:51:23Z</responseDate>
	<request identifier="oai:ojs.www.eurjchem.com:article/289" metadataPrefix="oai_dc" verb="GetRecord">https://www.eurjchem.com/index.php/eurjchem/oai</request>
	<GetRecord>
		<record>
			<header>
				<identifier>oai:ojs.www.eurjchem.com:article/289</identifier>
				<datestamp>2011-09-30T03:44:50Z</datestamp>
				<setSpec>eurjchem:ART</setSpec>
				<setSpec>driver</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Synthesis of novel 3,4-dihydroquinoxalin-2(1H)-one derivatives</dc:title>
	<dc:creator>Shabaan, Mohammed</dc:creator>
	<dc:creator>Taher, Azza Taher</dc:creator>
	<dc:creator>Osman, Eman Omar</dc:creator>
	<dc:subject xml:lang="en-US">Quinoxaline</dc:subject>
	<dc:subject xml:lang="en-US">3</dc:subject>
	<dc:subject xml:lang="en-US">4-dihydroquinoxalin</dc:subject>
	<dc:subject xml:lang="en-US">Antimicrobial activity</dc:subject>
	<dc:subject xml:lang="en-US">CK1 inhibitors</dc:subject>
	<dc:subject xml:lang="en-US">CDK5 inhibitors</dc:subject>
	<dc:subject xml:lang="en-US">GSK-3β inhibitors</dc:subject>
	<dc:description xml:lang="en-US">New derivatives of 3,4-dihydroquinoxaline-2(1H)-one were synthesized and characterized. Representative examples were evaluated for their antimicrobial and antifungal activities using Tetracycline and Nystatin as reference compound. One of the tested compounds 10a was found to exhibit slight activity against Staphylococcus aureus. Compounds 10b, 11b and 14b showed slight activity against Escherichia coli. Moreover, nineteen compounds were screened for their inhibition effect on CDK5, CK1, and GSK-3β. None of the tested compounds showed an inhibition activity below 10 µM concentration.</dc:description>
	<dc:publisher xml:lang="en-US">Atlanta Publishing House LLC</dc:publisher>
	<dc:date>2011-09-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://www.eurjchem.com/index.php/eurjchem/article/view/289</dc:identifier>
	<dc:identifier>10.5155/eurjchem.2.3.365-371.289</dc:identifier>
	<dc:source xml:lang="en-US">European Journal of Chemistry; Vol. 2 No. 3 (2011): September 2011; 365-371</dc:source>
	<dc:source>2153-2257</dc:source>
	<dc:source>2153-2249</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://www.eurjchem.com/index.php/eurjchem/article/view/289/PDF</dc:relation>
</oai_dc:dc>
			</metadata>
		</record>
	</GetRecord>
</OAI-PMH>
